[The effect of a peripheral androgenic blockade on plasma lipoproteins in hirsutism patients].
We studied the effect of flutamide, a peripheral androgenic blocking agent, 500 mg daily for 28 days in 7 non ovulating patients with hirsutism. Total and HDL cholesterol, triglycerides, testosterone and dehydroepiandrosterone sulphate (S-DHEA) plasma levels were measured in patients and in 6 non ovulating control women of similar age and weight. Only basal HDL levels were lower in patients than in controls (40.2 +/- 1.6 vs 51.4 +/- 3.3 mg/dl, p < 0.01). A decrease in S-DHEA levels was observed after flutamide in patients with hirsutism (3.2 +/- 0.4 to 2.1 +/- 0.4, p < 0.01) which may be attributed to the lowering of cortisol clearance induced by the drug. Total testosterone and plasma lipoproteins remained stable. Thus, peripheral androgenic blockade does not modify the decreased levels of HDL cholesterol in non ovulating patients with hirsutism.
Correa
R
R
Departamento de Endocrinología, Metabolismo y Nutrición, Escuela de Medicina Pontifica, Universidad Católica de Chile, Santiago.
Arteaga
E
E
López
X
X
Arteaga
A
A
Fernández
C
C
Acosta
A M
AM
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000704:Analysis of Variance; D000858:Anovulation / Q000097:blood / Q000188:drug therapy / Q000453:epidemiology; D003687:Dehydroepiandrosterone / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D005485:Flutamide / Q000008:administration & dosage*; D006628:Hirsutism / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008074:Lipoproteins / Q000097:blood / Q000187:drug effects*; D013739:Testosterone / Q000097:blood; D013997:Time Factors
D008074:Lipoproteins; D013739:Testosterone; D003687:Dehydroepiandrosterone; D005485:Flutamide; D000410:Alanine Transaminase
Efecto del bloqueo androgénico periférico sobre las lipoproteínas plasmáticas en pacientes hirsutas.